| abstract |
Provided are a colicin-fighting monoclonal antibody molecule or a derivative thereof, and a pharmaceutical composition containing the same, for ameliorating acute lung injury and acute worsening of pulmonary fibrosis.　The pharmaceutical composition of the present invention contains a monoclonal antibody molecule that fights against colicin, which is a peptide that stores a variety of staphylococcus strains including staphylococcus nepalensis, or a derivative of the monoclonal antibody molecule. |